Archive

Medical Category: Cardiovascular

No More Heparin for NSTEMI?

Background: The 2014 AHA guidelines for the management of NSTEMI, recommend unfractionated heparin with an initial loading dose of 60IU/KG (maximum 4,000 IU) with an initial infusion of 12 IU/kg/hr (maximum 1,000 IU/hr) adjusted per active partial thromboplastin time to maintain ...

Read More
Cardiovascular

REBEL Core Cast 2.0 – Cardiotoxic Drugs

Take Homes Calcium Channel Blocker (CCB) toxicity usually present with bradycardia and hypotension, but with preserved mental status. This can help differential from Beta Blocker (BB) toxicity, where the patients often have altered mental status. Hyperglycemia is the other hallmark ...

Read More
Cardiovascular

30-Day Outcomes in Syncope vs Near-Syncope

Background: Syncope, defined as a transient loss of consciousness with spontaneous and complete recovery to pre-event status, is a common emergency department (ED) presentation. Near-syncope is frequently seen as well. Unlike syncope, near-syncope has a more nebulous definition often thought of ...

Read More
Cardiovascular

The ORBITA Trial: PCI vs Placebo Procedure for Angina Relief in Stable Angina

Background:In the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial , there was no difference in MI and death rates between patients with stable coronary artery disease who underwent PCI and controls. In stable angina, the primary goal of ...

Read More
Cardiovascular

SCOT-HEART: CCTA Decreases Long-Term Risk of MI and Death?

Background: CT coronary angiography (CTCA) is a relatively new technology that has gained popularity over the past few years in evaluating patients presenting with chest pain. CTCA is an anatomic test that has been shown to increase downstream testing and increase healthcare ...

Read More
Cardiovascular

Sponsored